Tinea Versicolor

Clinical guidelines for managing superficial Malassezia fungal overgrowth, analyzing skin scrapings and fluorescent findings, and reviewing topical and oral antifungal treatments.

⏱️ 4 min read

Table of Contents

🧠 Standard of Care & Symptoms

Tinea Versicolor, also termed Pityriasis Versicolor, is a common, benign, superficial fungal infection of the stratum corneum, characterized by pigmentary changes.

πŸ”¬ Diagnostics & KOH Scrapings

Diagnosis is usually clinical, confirmed easily by rapid bedside tests.

Azelaic Acid & Tyrosinase Inhibition

The characteristic skin discoloration (spots) is a direct consequence of yeast biochemical metabolism:

πŸ’Š Topical & Systemic Antifungals

Therapy focuses on clearing the fungal overgrowth. Pigmentary changes take several months to normalize after the fungus is cleared.

Topical Regimens (First-Line)

Oral Antifungals (For Widespread or Recurrent Cases)

πŸ”¬ Active Clinical Trials

Clinical trials are currently evaluating novel topical formulation delivery systems, prophylactic regimens to prevent summer recurrences, and sebum-regulating topical agents.

NCT06922425: Quick-Drying Topical Antifungal Foam

A Phase III clinical trial evaluating a novel, quick-drying topical antifungal foam designed for easy application over large trunk surface areas.

Key Inclusion: Age ≥ 12, clinically diagnosed Tinea Versicolor affecting ≥ 5% body surface area (BSA), positive microscopic KOH preparation at baseline, and willing to avoid other topical skin therapies.
NCT07050133: Seasonal Prophylactic Recurrence Prevention

Testing a monthly prophylactic topical formulation to prevent seasonal recurrences in hyperhidrosis patients.

Key Inclusion: Age ≥ 18, history of ≥ 2 documented episodes of recurrent Tinea Versicolor during preceding summer seasons, and willing to undergo monthly skin surveillance.
NCT07119022: Skin Microbiome Shifts Under Oral Fluconazole

Comparing skin microbiome shifts before and after oral fluconazole therapy in pityriasis versicolor.

Key Inclusion: Age 18 to 65, active untreated Pityriasis Versicolor, no systemic antifungal use within 3 months, and agreeing to avoid antibacterial soaps during the study.
Important: Browse actively recruiting clinical trials in our Clinical Trials Catalogue to find a local study.

πŸ—ΊοΈ Next Steps After Diagnosis

If you have recently been diagnosed with Tinea Versicolor, establish these skin care habits:

  1. Complete Your Prescribed Treatment: Complete the full course of topical selenium sulfide or ketoconazole, even if scaling resolves.
  2. Manage Pigmentary Expectations: The hypopigmented spots do not mean treatment failed. The fungus produces **azelaic acid**, which temporarily inhibits melanin production. Normal skin color returns only after exposure to sunlight over 3 to 6 months.
  3. Implement Summer Prophylaxis: If you experience frequent summer recurrences, apply selenium sulfide shampoo or ketoconazole shampoo to your body weekly as a wash during hot, humid months.
  4. Wear Loose-Fitting, Breathable Clothing: Malassezia thrives in warm, moist environments. Wear cotton clothing and shower immediately after heavy exercise.

❓ Patient FAQ

Q: Is tinea versicolor contagious?
A: No. The yeast that causes tinea versicolor is a normal inhabitant of everyone's skin. Overgrowth only occurs due to individual host factors (like oily skin, heat, or sweating), so you cannot catch it from or transmit it to someone else.

Q: Why did my spots not tan after using antifungal cream?
A: The yeast produces azelaic acid, a compound that damages melanocytes (pigment-producing cells) and blocks melanin synthesis. Even though the antifungal cream killed the yeast, the melanocytes need time to recover. Sun exposure will help stimulate pigment production, but it takes several months for color to match the surrounding skin.

Get the Free 2026 Clinical AI Directory

Email us at caleb@openphr.org to receive our exclusive directory of over 150 open-source models and clinical trial databases.

Request Directory via Email